docetaxel anhydrous has been researched along with importazole in 1 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (importazole) | Trials (importazole) | Recent Studies (post-2010) (importazole) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 29 | 0 | 23 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, L; Cao, Q; Chen, K; Huang, X; Li, X; Liu, L; Lou, N; Qiu, B; Ruan, H; Wang, K; Xiao, W; Xu, G; Yang, H; Yuan, C; Zhang, X | 1 |
1 other study(ies) available for docetaxel anhydrous and importazole
| Article | Year |
|---|---|
Calpain and AR-V7: Two potential therapeutic targets to overcome acquired docetaxel resistance in castration-resistant prostate cancer cells.
Topics: Androgens; Calpain; Cell Line, Tumor; Docetaxel; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Protein Isoforms; Quinazolines; Receptors, Androgen; Signal Transduction; Taxoids | 2017 |